Sacral neuromodulation and pregnancy: Results of a national survey carried out for the neuro‐urology committee of the French Association of Urology (AFU)

Roulette, P.; Castel-Lacanal, É.; Sanson, Sylvain; Caremel, R.; Phé, Véronique; Bart, S.; Duchene, Franck; Sèze, M. de; Even, A.; Manunta, A.; Scheiber-Nogueira, M.C.; Mouracadé, Pascal; Loche, Catherine-Marie; Chartier‐Kastler, Emmanuel; Ruffion, A.; Karsenty, G.; Gamé, X.

doi:10.1002/nau.23349

Cited by 11 publications

(8 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…They found no negative effects of SNM on the fetus and the mother. These observations were confirmed by a national survey carried out for the neurology committee of the French Association of Urology [27]. In total, 27 pregnancies among 21 women were recorded.…”

Section: Complications With Keeping the Device On/offsupporting

confidence: 55%

“…After delivery, SNM efficacy must be checked to exclude displacement or electrode damage. Roulette and colleagues reported that SNM efficacy deteriorated in 20% of women postpartum, irrespective of the mode of delivery [ 27 ]. In most of these cases, the reprogramming of the device was sufficient to restore its proper functioning, with explantation hardly ever being required.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Sacral Neuromodulation in Pregnant Women—A Case Report and Literature Review

Szymański

Słabuszewska-Jóźwiak

Jakiel

2022

IJERPH

View full text Add to dashboard Cite

Millions of women around the world suffer from an overactive bladder and urinary retention. A significant number of them are of reproductive age. For 25 years, SNM has been an effective therapy for treatment-resistant hyperactive bladder and idiopathic urinary retention. The paper presents a case of a 35-year-old pregnant woman with an overactive bladder resistant to pharmacological treatment, who responded positively to sacral neuromodulation. The patient decided against deactivating the neuromodulator and, after an uneventful course of pregnancy, she gave birth by a caesarean section to a healthy female infant. The use of SNM in pregnant patients remains a constant clinical challenge. The current literature was reviewed, but published studies do not provide a clear answer. Further studies with a long follow-up period are necessary to determine more accurately the effects of SNM therapy on the fetus and the course of pregnancy. Currently, it is recommended to deactivate SNM during pregnancy. However, it seems that an individual approach to the patient with information on the risks and benefits of continuing or discontinuing therapy should be the current procedure.

show abstract

Section: Complications With Keeping the Device On/offsupporting

confidence: 55%

Section: Discussionmentioning

confidence: 99%

Sacral Neuromodulation in Pregnant Women—A Case Report and Literature Review

Szymański

Słabuszewska-Jóźwiak

Jakiel

2022

IJERPH

View full text Add to dashboard Cite

show abstract

“…For this reason, the parent company as well as numerous urological and gynecological associations-including the International Urogynaecological Association (IUGA)-suggests keeping implantable pulse generators (IPGs) off during pregnancy, as "the effect of neuromodulation on pregnancy is largely unknown." A national survey carried out by emailing all the urologists listed in the Interstim National Registry in France showed that deactivation of the device was advised in 18.5% of cases while trying to conceive and during the first trimester in the remaining 81.5% cases [4]. Two systematic reviews are currently available on the topic.…”

Section: Discussionmentioning

confidence: 99%

Do you really want to deactivate your sacral neuromodulation device during pregnancy? A single center case series

2020

View full text Add to dashboard Cite

Introduction and hypothesis The main objective of the study is to assess the efficacy and safety of sacral neuromodulation (SNM) during pregnancy. Methods We retrospectively enrolled patients who underwent SNM implantation in our center and subsequently became pregnant. The indication for SNM, timing of device de-activation (if performed), course of pregnancy and urological complications, duration of labor, childbirth term, delivery mode, congenital abnormalities and SNM dysfunctions after delivery were recorded. Results Fourteen pregnancies were recorded among 11 women undergoing SNM. Indications for device implantation were urinary retention (7 cases) and dysfunctional voiding (4 cases). Two patients carried on two and three pregnancies, respectively, with the device turned off since the first trimester. They both had to return to self-catheterization and developed recurring urinary tract infections. No major urological complications were recorded among the remaining nine women that kept the device on during pregnancy. A cesarean section was performed in four cases for obstetric reasons, and in seven cases it was planned by the urologist and gynecologist to avoid lead damage/displacement. Three pregnancies resulted in a vaginal delivery, and no association with term of delivery or duration of labor was observed. No congenital abnormalities related to SNM or lead displacement are reported, and only one patient required device removal because of significant loss of efficacy after childbirth. Conclusions The use of SNM during pregnancy appears to be safe, without morbidity for the fetus. Moreover, risks associated with switching the device off may be greater than benefits and justify maintaining the electrical stimulation throughout pregnancy.

show abstract

“…Dans ce dernier cas, chez une patiente implantée, il est recommandé d'arrêter la stimulation dès le début de la grossesse et probablement dès l'arrêt de toute contraception. Il a été récemment rapporté qu'après l'accouchement, la remise en route du système permettait de retrouver la même efficacité dans 80 % des cas [41].…”

Section: La Neuromodulation Sacréeunclassified

Traitement du syndrome clinique d’hyperactivité vésicale non neurologique réfractaire

Gamé

Phé

2020

Progrès en Urologie

View full text Add to dashboard Cite

Sacral neuromodulation and pregnancy: Results of a national survey carried out for the neuro‐urology committee of the French Association of Urology (AFU)

Cited by 11 publications

References 18 publications

Sacral Neuromodulation in Pregnant Women—A Case Report and Literature Review

Sacral Neuromodulation in Pregnant Women—A Case Report and Literature Review

Do you really want to deactivate your sacral neuromodulation device during pregnancy? A single center case series

Traitement du syndrome clinique d’hyperactivité vésicale non neurologique réfractaire

Contact Info

Product

Resources

About